abstract |
The present invention relates to novel hydroxyethylene compounds having Asp2(β - secretase, BACEl or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β - amyloid levels or β - amyloid deposits, particularly Alzheimer's disease. |